Psychoeducation Programmes - Patients With Bipolar Disorder

Bipolar Disorder Type I or II (According to DSM-5) Clinical Trial

— AppEduc-BD  

Official title:

Non-inferiority Study Comparing Two Psychoeducation Programmes (Mobile Application Versus Face-to-face Psychoeducation Group) in a Population of Patients With Bipolar Disorder

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04775498
• Other study ID #: PREPS 2017 SAMALIN
• Status: Recruiting
• Phase: N/A
• Start date: February 1, 2021
• Est. completion date: February 1, 2025

Study information

• Verified date: February 2021
• Source: University Hospital, Clermont-Ferrand
• Contact: Lise Laclautre
• Phone: 33.4.73.754.963
• Email: promo_interne_drci[@]chu-clermontferrand.fr
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This is a controlled, randomized, prospective, open-label, non-inferiority trial lasting 12 months. The effectiveness of using a psychoeducational smartphone application (SIMPLe) will be compared to the effectiveness of face-to-face group psychoeducation.

Description:

Bipolar disorder (affecting 3 to 5% of French population) is characterized by the recurrence of severe symptomatic periods (depression, mania, hypomania) and interepisodic periods characterized by the persistence of residual symptoms, impaired psychosocial functioning and quality of life. The combination of psychosocial strategies with drug treatment is associated with an improvement in the prognosis of the disease. Among these complementary strategies, psychoeducation has been shown to be effective in reducing the risk of recurrence, the length of hospital stays and improving compliance. It improves an individual's understanding and knowledge of their disorder and its various treatments. Despite its effectiveness, psychoeducation for bipolar disorder remains relatively scarcely applied in France due to a limited healthcare offer (44 available programmes labeled by the Regional Health Agencies in 2017).

In recent years, a significant number of smartphone applications have been developed in the field of mental health. To date, none of these applications has proven effective in patients with bipolar disorder. In this context, the Institute of Neuroscience of Barcelona has developed a "SIMPLe" application to assess and record a subject's symptoms and deliver personalized psychoeducation. In terms of efficacy, a study has shown the interest of this application in improving biological rhythms, thereby reducing the risk of relapse and improving psychosocial functioning and the quality of life of patients suffering from bipolar disorder in remission phase. This application has been translated and adapted into French as part of a partnership with the Barcelona Institute of Neuroscience. However, the benefits of this type of application in terms of effectiveness, accessibility or reduction of health costs have never been studied in comparison to face-to-face psychoeducation programmes. This research project therefore represents a real opportunity to evaluate for the first time the effectiveness of an application allowing the delivery of personalized psychoeducation in comparison to a face-to-face group psychoeducation program (reference treatment for relapse prevention).

The SIMPLe app includes 5 daily questions (mood, energy, sleep, irritability, medication adherence) that will assess different areas associated with bipolar disorder. The user will also receive a weekly test to determine the presence and intensity of depressive or manic symptoms. Daily and personalized psychoeducation messages (adapted to the answers to the tests carried out) will be sent to the user by notifications. The app contains a bank of around 400 psychoeducational messages, based on Prof. Vieta and Dr Colom's Psychoeducation Manual for Bipolar Disorders.

Eligible patients, after obtaining their consent, will be randomized (i) either in the face-to-face psychoeducation group which will consist of the participation by the patients in all the sessions of a therapeutic education program (labeled and controlled by their Regional Health Agency) of the investigator center, (ii) or in the SIMPLe application group and will benefit from access to the application via a code that will be sent to them.

Three additional visits to the usual care are planned (assessment visit, 6 months and 12 months). At each visit, patients must complete questionnaires (CSRI, YMRS, MADRS, FAST, MARS, WHOQOL-BREF and EQ-5D).

The hypothesis formulated by the investigator is that a psychoeducational strategy using the SIMPLe smartphone application has an effect comparable to participation in a face-to-face psychoeducation group, in term of the recurrence prevention in a sample of stabilized patients with bipolar disorder (at 12 months). The recurrence rate is defined by the percentage of patients having presented a mood episode of bipolar disorder, namely a major depressive episode, manic or hypomanic episode, according to the criteria of DSM-5 and on the basis of the judgment of the clinician since the beginning of the intervention.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 352
• Est. completion date: February 1, 2025
• Est. primary completion date: February 1, 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Suffering from bipolar disorder (type 1 or 2) according to DSM-5 criteria

• Not presenting a mood episode according to DSM-5 criteria

• Stable for at least 1 month with scores on YMRS < 8 and MADRS < 8

• Owning a smartphone

• Agreeing to attend group psychoeducation sessions

• Having no problem understanding fluent French

• Having given free and informed consent and signed the consent to participate in the study

• Available for 12 onth follow-up

Exclusion Criteria:

• Not having a smartphone compatible with the SIMPLe application

• Cannot attend psychoeducation group sessions on a regular basis

• Not having given their consent to participate in the study or unable to give their informed consent

• Not affiliation with a social security scheme

• Having a legal protection measure (safeguard of justice or guardianship)

Related Conditions & MeSH terms

• Bipolar Disorder
• Bipolar Disorder Type I or II (According to DSM-5)
• Disease

Intervention

Behavioral:
• Face-to-face psychoeducation group
All of the investigation centers participating in this study have a psychoeducation programme on bipolar disorders labeled and monitored by their Regional Health Agency. For this, he must respect the decree of January 14, 2015 relating to the specifications of therapeutic education programs for the patient. Patients will be receive by an investigator, for inclusion and baseline evaluation and at 6 and 12 months after inclusion. During this meeting, investigator and patient will be complete 7 questionnaires (about disease, treatment observance and quality of life), investigator will collect treatment, style life and adverse event(s).
• SIMPLe mobile application
The experimental intervention consists of 12 months use SIMPLe smartphone application who has been developed by the Barcelona Institute of neuroscience. The purpose of this application is to deliver individualized psychoeducation messages to the patient's clinical condition. The psychoeducational messages correspond to the contents of the different modules and sessions carried out in face-to-face psychoeducation groups (Colomm & Vieta ; 2015). Patients will be receive by an investigator for inclusion and baseline evaluation, at 6 and 12 months after inclusion. During this meeting, investigator and patient will be complete 7 questionnaires (about disease, treatment observance and quality of life), investigator will collect treatment, style life and adverse event(s).

Locations

Country	Name	City	State
France	CH Charles Perrens	Bordeau
France	CHU - Gabriel Montpied	Clermont-Ferrand
France	CHU - Hôpital Lapeyronie	Montpellier
France	CHU	Nantes
France	CHU - Hôpital Universitaire Carémeau	Nîmes
France	APHP - Centre Hospitalier Henri Mondor	Paris
France	APHP - Hôpital Fernand-Widal	Paris
France	CH Saint-Anne	Paris
France	CHI HC site rives du Doubs Pontarlier	Pontarlier
France	CHU - Hôpital de Psychiatrie	Toulouse

Sponsors (1)

Lead Sponsor	Collaborator
University Hospital, Clermont-Ferrand

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Recurrence rate	Measure the difference of recurrence rate (defined by the percentage of patients having presented a mood episode of bipolar disorder, namely a major depressive episode, manic or hypomanic episode, according to the criteria of DSM-5 and on the judgment of the clinician since the beginning of the intervention) between patients who participated to face-to-face psychoeducation group and patients who use SIMPLe application	12 months after inclusion
Secondary	Hospitalization number	Measure the difference of number and duration of hospitalization between patients who participated to face-to-face psychoeducation group and patients who use SIMPLe application	6 months after inclusion
Secondary	Hospitalization number	Measure the difference of number and duration of hospitalization between patients who participated to face-to-face psychoeducation group and patients who use SIMPLe application	12 months after inclusion
Secondary	Maniac and depressive symptomatology intensity	Measure the difference of maniac and depressive symptomatology intensity between patients who participated to face-to-face psychoeducation group and patients who use SIMPLe application. These measures are based on YMRS (for maniac symptomatology) questionnaire.	6 months after inclusion.
Secondary	Maniac and depressive symptomatology intensity	Measure the difference of maniac and depressive symptomatology intensity between patients who participated to face-to-face psychoeducation group and patients who use SIMPLe application. These measures are based on YMRS (for maniac symptomatology) questionnaire.	12 months after inclusion.
Secondary	Maniac and depressive symptomatology intensity	Measure the difference of maniac and depressive symptomatology intensity between patients who participated to face-to-face psychoeducation group and patients who use SIMPLe application. These measures are based on MADRS (for depressive symptomatology) questionnaires.	6 months after inclusion.
Secondary	Maniac and depressive symptomatology intensity	Measure the difference of medication compliance between patients who participated to face-to-face psychoeducation group and patients who use SIMPLe application. This measure is based on MARS (Medication Adherence Report Scale) questionnaire.	6 months after inclusion.
Secondary	Medication compliance	Measure the difference of medication compliance between patients who participated to face-to-face psychoeducation group and patients who use SIMPLe application. This measure is based on MARS (Medication Adherence Report Scale) questionnaire.	12 months after inclusion.
Secondary	Psychosocial functioning	Measure the difference of psychosocial functioning between patients who participated to face-to-face psychoeducation group and patients who use SIMPLe application. This measure is based on FAST (Functional Analysis Screening Tool ) questionnaire.	6 months after inclusion.
Secondary	Psychosocial functioning	Measure the difference of psychosocial functioning between patients who participated to face-to-face psychoeducation group and patients who use SIMPLe application. This measure is based on FAST (Functional Analysis Screening Tool ) questionnaire.	12 months after inclusion.
Secondary	Evaluation of Quality of life	Measure the difference of quality of life between patients who participated to face-to-face psychoeducation group and patients who use SIMPLe application. This measure is based on WHOQOL-BREF (World Health Organization Quality of Life) questionnaire.	6 months ater inclusion
Secondary	Evaluation of Quality of life	Measure the difference of quality of life between patients who participated to face-to-face psychoeducation group and patients who use SIMPLe application. This measure is based on WHOQOL-BREF (World Health Organization Quality of Life) questionnaire.	12 months ater inclusion
Secondary	Cost efficiency	Cost efficiency evaluation of SIMPLe application using CSRI (Client Service Receipt Inventory) questionnaire	12 month after inclusion
Secondary	Cost / utility ratio	Evaluation of cost / utility ratio of SIMPLe application using the EQ-5D (EuroQol 5 Dimensions) questionnaire.	12 month after inclusion
Secondary	Qualitative analysis	Some patients of SIMPLe application group (4 womens and 4 mens < 30 years, 4 womens and 4 mens 30 to 50 years and 4 womens and 4 mens > 50 years) will participate in an individual interview. These semi-structured individual interviews will be carried out by a psychologist. During these interviews the perception and use of the SIMPLe application by patients will be gathered (both positive opinions and negative criticisms and possible obstacles to its use).	12 months after inclusion